ABM	agent-based model
CTL	cytotoxic T lymphocyte
FDA	US Food & Drug Administration
FasL	Fas ligand
FGFR3	fibroblast growth factor receptor 3
HA	high antigen
ICI	immune checkpoint inhibitor
IL-2	interleukin-2
ISF	immune stimulatory factor
LA	low antigen
ODE	ordinary differential equation
PD-1	programmed cell death protein 1
PD-L1	programmed death-ligand 1
TME	tumor microenvironment